Technical reference
Knowledge Base
Chemistry, manufacturing and controls data for seven compounds, with regulatory classification and the analytical record around it. Compounds are grouped by the regulatory regime that applies to them, because those regimes are not comparable and the same framing should not be used for all three.
All entries last reviewed on or after 2026-07-30 by HelixEvoLabs Research Team
Regulated as medicinal products
Incretin therapeutics
Compounds regulated as medicinal products. Authorisation status differs by jurisdiction, by brand and by route of administration, and one compound in this group holds no marketing authorisation anywhere.
Semaglutide
Technical, analytical and regulatory reference for semaglutide as a manufactured peptide material across its injectable and oral routes.
- EU
- UK
- US
Tirzepatide
Technical, analytical and regulatory reference for tirzepatide as a manufactured synthetic peptide material.
- EU
- UK
- US
Orforglipron
Technical, analytical and regulatory reference for orforglipron as a manufactured small-molecule material.
- US
- EU
- UK
Retatrutide
Investigational — no marketing authorisation
Technical and regulatory reference for retatrutide, an investigational peptide holding no marketing authorisation in any jurisdiction.
- US
- EU
- UK
- AU
- CA
- CH
Regulated as cosmetic ingredients
Copper tripeptides
Compounds regulated as cosmetic ingredients rather than as medicinal products. Ingredient safety assessment, not marketing authorisation, is the applicable regulatory framework, and no medicinal claims are made for them.
No settled classification
Metabolic cofactors
Compounds with no settled regulatory classification across major jurisdictions. Classification varies by form and by route of administration, and remains contested in several territories.